skip to main content
primary care & preventionformula

QRISK3 (10-year CVD Risk)

iatroX editorial team · Updated · Record checked · editorial policy

QRISK3 estimates the 10-year risk of cardiovascular disease (heart attack or stroke) for adults aged 25–84 in the UK. It is the NICE-recommended CVD risk tool and uses clinical, demographic, and deprivation data including conditions not captured by other risk scores (SLE, atypical antipsychotics, migraine, erectile dysfunction, severe mental illness).

calculate with the official tool

Use the official calculator for this model, then return here for interpretation and related guidance.

Open the official QRISK3 calculator ↗
evidence

derivation

Developed by Hippisley-Cox et al. (BMJ 2017) from the QResearch database of >10 million UK primary care patients. Updated from QRISK2 to include additional risk factors (SLE, migraine, antipsychotics, corticosteroids, erectile dysfunction, severe mental illness, CKD).

validation

Validated in 2.1 million patients separate from the derivation cohort. Well calibrated across age groups, ethnicities, and deprivation quintiles in the UK population. AUROC ~0.86 for women, ~0.84 for men.

guideline endorsements

NICE NG238 recommends QRISK3 for primary cardiovascular risk assessment in eligible adults and offering a statin at a 10-year risk of 10% or more, following shared decision making.

regional interpretation
UK: QRISK3 is the NICE-recommended tool. Threshold ≥10% for statin offer. Calculate at qrisk.org.
US: Use ASCVD Pooled Cohort Equations instead.
EU: Use SCORE2/SCORE2-OP instead.
references
  1. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099.PMID: 28536104
  2. NICE Clinical Guideline CG181. Cardiovascular disease: risk assessment and reduction, including lipid modification. 2014 (updated 2023).link ↗
  3. Supporting guidance — qrisk.org (checked 14 November 2026).link ↗
  4. Supporting guidance — nice.org.uk (checked 14 November 2026).link ↗
Continue exploring

Explore these topics in the iatroX reference and learning libraries.